Track topics on Twitter Track topics that are important to you
Ceros Pharmaceuticals is developing compounds to treat osteoporosis. The company is developing important new drug targets that control bone mass and is now in pre-clinical development of compounds. Please contact us to obtain detailed information.
Suite 112-113 Wellington House, East Road
Phone: +44 (0) 1223 451 338
Fax: +44 (0) 1223 451 110
CRANBURY, N.J., Sept. 08, 2017 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) today announced that it entered into a Purchase Agreement on September 7, 2017 with GMS Tenshi Holdings Pte. Li...
JERSEY, Channel Islands, Sept. 13, 2017 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive...
MELBOURNE, Australia, Sept. 18, 2017 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix”, the “Company”) is pleased to announce that Mr. Kevin McCann AM and Dr. Mark Nelson have be...
Vical plans to initiate Phase 2 trial of VL-2397 for the treatment of invasive aspergillosis in 4Q 2017 Management to host conference call on October 3rd at 12:00 pm ET to discuss the Phase 2 tri...
HONG KONG, CHINA -- (Marketwired) -- 10/03/17 -- Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group") (HKSE: 2633), a leading company engaged in the research, development, productio...
Performance evaluation studies confirm required concordance levels for all assaysVerification and validation studies to commence shortly European field trials still expected to be completed in CY17...
HONG KONG, CHINA -- (Marketwired) -- 09/19/17 -- MetLife Hong Kong* announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabete...
SummaryThe global Virgin Coconut Oil market will reach xxx Million USD in 2017 with CAGR xx% from 20182025. The main contents of the report including:Global market size and forecastRegional market siz...
Famotidine Tablets, USP 20 mg
Facility Maintenance Instant Hand Sanitizer HS-67
Amar ICE GEL
Ceros Pharmaceuticals is developing compounds to treat osteoporosis. The company is developing important new drug targets that control bone mass and is now in pre-clinical development of compounds. Pl...
Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...
Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...
VASUDHA PHARMA CHEM LIMITED (VPCL) is a Company promoted by a team of accomplished technocrats for Bulk Drug industry with a total capital of Rupees 153 million ( US $ 5Million).All the promoters of V...
We have published hundreds of Ceros Limited news stories on BioPortfolio along with dozens of Ceros Limited Clinical Trials and PubMed Articles about Ceros Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ceros Limited Companies in our database. You can also find out about relevant Ceros Limited Drugs and Medications on this site too.
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...